MARCOS
GONZÁLEZ DÍAZ
Ikertzailea 1993-2023 tartean
Universidade Federal do Rio de Janeiro
Río de Janeiro, BrasilUniversidade Federal do Rio de Janeiro -ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2023
2017
-
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
Leukemia, Vol. 31, Núm. 10, pp. 2094-2103
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477